EGF and hepatocellular carcinoma: The EGF-mediated pathway was reported to be deregulated in HCC[22] and to be linked to the HBx-NF-κB pathway, a part of the inflammation-fibrosis-cancer axis of the liver, via a non-receptor tyrosine phosphatase SHP2.